Expression of GABARAP in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

GABARAP is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1040.17

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1176.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1795.3
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	1767.1
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1680.6
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1664.8
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1615.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1599.8
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1552.4
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	1542.2
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1540.4
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1531.7
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1523.0
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1498.0
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1477.8
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1455.4
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1451.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1450.3
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1441.7
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	1440.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1434.1
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	1432.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1424.3
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1402.2
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1396.1
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1390.8
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1385.4
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1381.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1369.7
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1361.8
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1357.1
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1350.5
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1345.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1336.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1330.2
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1323.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1322.6
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	1318.5
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1309.7
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1307.7
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1302.6
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1302.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1294.6
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1292.9
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1286.2
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1285.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1276.5
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1274.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1274.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1269.5
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1269.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1267.1
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1265.7
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1251.0
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1249.4
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	1248.8
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1241.8
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1240.5
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1234.4
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1230.8
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1229.6
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1227.4
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1216.7
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1215.7
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1211.7
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1211.5
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1211.0
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1210.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1203.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1192.8
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	1190.1
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1189.4
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1186.5
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1182.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1177.9
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1176.0
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1173.6
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1172.1
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1166.5
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1160.2
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1157.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1152.9
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1139.3
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1130.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1128.3
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1123.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1119.4
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1118.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1114.1
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1111.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1108.2
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1105.1
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1098.8
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1096.5
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1084.3
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1078.2
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1076.5
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	1072.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1070.7
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1070.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1060.4
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1058.1
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1052.1
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1047.2
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1042.4
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1041.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1039.2
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1027.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1025.2
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1018.8
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1009.7
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1008.5
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	997.4
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	994.8
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	970.1
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	964.5
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	962.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	958.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	957.8
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	955.5
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	955.1
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	954.2
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	947.7
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	939.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	935.8
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	929.2
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	912.8
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	912.6
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	903.4
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	873.9
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	856.2
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	848.3
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	814.8
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	803.5
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	797.4
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	778.5
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	760.2
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	752.7
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	727.2
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	706.5
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	681.3
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	672.7
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	547.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

GABARAP is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 79.36

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

88.9

Number of samples

Samples

Sample	Description	pTPM
AK030	N, NA, stage:NA, dead, 120 days	133.7
AK041	N, NA, stage:NA, alive, 810 days	133.2
AK002	N, NA, stage:NA, dead, 570 days	132.9
AK076	N, NA, stage:NA, alive, 660 days	125.4
AK156	N, NA, stage:NA, dead, 330 days	124.8
AK066	N, NA, stage:NA, alive, 960 days	124.0
AK124	N, NA, stage:NA, alive, 1920 days	121.8
AK072	N, NA, stage:NA, dead, 150 days	117.9
AK085	N, NA, stage:NA, alive, 660 days	113.8
AK055	N, NA, stage:NA, dead, 240 days	112.4
AK081	N, NA, stage:NA, dead, 180 days	112.2
AK167	N, NA, stage:NA, dead, 180 days	111.1
AK218	N, NA, stage:NA, dead, 180 days	105.2
AK043	N, NA, stage:NA, alive, 660 days	104.1
AK134	N, NA, stage:NA, dead, 360 days	103.8
AK185	N, NA, stage:NA, alive, 330 days	103.8
AK005	N, NA, stage:NA, dead, 240 days	102.5
AK015	N, NA, stage:NA, alive, 720 days	101.9
AK103	N, NA, stage:NA, alive, 1320 days	98.0
AK091	N, NA, stage:NA, dead, 210 days	97.8
AK199	N, NA, stage:NA, alive, 1860 days	96.5
AK117	N, NA, stage:NA, dead, 210 days	96.0
AK006	N, NA, stage:NA, dead, 360 days	94.6
AK213	N, NA, stage:NA, alive, 2010 days	94.5
AK149	N, NA, stage:NA, dead, 420 days	92.1
AK068	N, NA, stage:NA, alive, 360 days	91.8
AK188	N, NA, stage:NA, alive, 420 days	90.9
AK183	N, NA, stage:NA, alive, 360 days	90.5
AK099	N, NA, stage:NA, dead, 420 days	90.0
AK079	N, NA, stage:NA, dead, 210 days	89.1
AK195	N, NA, stage:NA, dead, 390 days	87.0
AK003	N, NA, stage:NA, dead, 600 days	86.7
AK158	N, NA, stage:NA, dead, 360 days	85.7
AK049	N, NA, stage:NA, dead, 180 days	85.1
AK142	N, NA, stage:NA, alive, 90 days	84.0
AK165	N, NA, stage:NA, alive, 360 days	83.4
AK102	N, NA, stage:NA, alive, 1740 days	80.7
AK231	N, NA, stage:NA, dead, 240 days	78.0
AK236	N, NA, stage:NA, dead, 360 days	76.5
AK071	N, NA, stage:NA, dead, 540 days	76.5
AK074	N, NA, stage:NA, alive, 300 days	75.0
AK153	N, NA, stage:NA, dead, 240 days	72.0
AK216	N, NA, stage:NA, dead, 360 days	71.9
AK139	N, NA, stage:NA, dead, 270 days	71.1
AK051	N, NA, stage:NA, dead, 360 days	67.6
AK123	N, NA, stage:NA, dead, 180 days	67.1
AK178	N, NA, stage:NA, dead, 240 days	65.9
AK035	N, NA, stage:NA, dead, 210 days	65.5
AK226	N, NA, stage:NA, dead, 360 days	65.3
AK227	N, NA, stage:NA, alive, 300 days	65.3
AK088	N, NA, stage:NA, dead, 360 days	65.2
AK098	N, NA, stage:NA, dead, 660 days	62.7
AK133	N, NA, stage:NA, dead, 360 days	61.8
AK173	N, NA, stage:NA, dead, 180 days	60.2
AK205	N, NA, stage:NA, dead, 120 days	59.6
AK100	N, NA, stage:NA, alive, 960 days	52.7
AK089	N, NA, stage:NA, dead, 330 days	47.0
AK053	N, NA, stage:NA, dead, 300 days	35.7
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0204330003	Normal	1.3
CPT0204340003	Normal	0.9
CPT0204360003	Normal	0.9
CPT0204420003	Normal	0.8
CPT0204390003	Normal	0.8
CPT0204410003	Normal	0.8
CPT0204400003	Normal	0.7
CPT0204350003	Normal	0.6
CPT0201710003	Tumor	0.6
CPT0206110003	Tumor	0.5
CPT0204380003	Normal	0.5
CPT0104220003	Tumor	0.4
CPT0168270003	Tumor	0.4
CPT0190240004	Tumor	0.3
CPT0206230003	Tumor	0.3
CPT0209440003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0217880003	Tumor	0.2
CPT0189650004	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0093590003	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0093550003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0104330003	Tumor	0.1
CPT0125510003	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0182580003	Tumor	0.1
CPT0182550003	Tumor	0.1
CPT0218670003	Tumor	0.1
CPT0217100003	Tumor	0.1
CPT0206880003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0196850003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0127480003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0218770003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0206450003	Tumor	-0.1
CPT0162140003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0189570004	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0204370003	Normal	-0.1
CPT0206330003	Tumor	-0.1
CPT0167640003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0205670004	Tumor	-0.1
CPT0224540004	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0207090003	Tumor	-0.2
CPT0167970003	Tumor	-0.2
CPT0078580003	Tumor	-0.2
CPT0127420003	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0190360004	Tumor	-0.2
CPT0217710008	Tumor	-0.2
CPT0189460003	Tumor	-0.2
CPT0216920008	Tumor	-0.2
CPT0225760003	Tumor	-0.2
CPT0168380003	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0089150003	Tumor	-0.2
CPT0205570003	Tumor	-0.3
CPT0205890003	Tumor	-0.3
CPT0206670004	Tumor	-0.3
CPT0186100003	Tumor	-0.3
CPT0168480003	Tumor	-0.3
CPT0207030003	Tumor	-0.3
CPT0206000004	Tumor	-0.3
CPT0092440003	Tumor	-0.3
CPT0225730003	Tumor	-0.3
CPT0087950003	Tumor	-0.3
CPT0093360003	Tumor	-0.3
CPT0218690004	Tumor	-0.4
CPT0219080004	Tumor	-0.4
CPT0217190003	Tumor	-0.4
CPT0208980003	Tumor	-0.4
CPT0224390004	Tumor	-0.4
CPT0206780003	Tumor	-0.4
CPT0228220003	Tumor	-0.4
CPT0093510003	Tumor	-0.4
CPT0168830003	Tumor	-0.5
CPT0087730003	Tumor	-0.5
CPT0087570003	Tumor	-0.5
CPT0161730003	Tumor	-0.5
CPT0189850004	Tumor	-0.5
CPT0123530003	Tumor	-0.5
CPT0162020003	Tumor	-0.6
CPT0218330004	Tumor	-0.6
CPT0093450003	Tumor	-0.7
CPT0079790003	Tumor	-0.7
CPT0167530003	Tumor	-0.9
CPT0217430008	Tumor	-0.9
CPT0171580008	Tumor	-0.9
CPT0205780003	Tumor	-1.0
CPT0217000004	Tumor	-1.1
CPT0168080003	Tumor	-1.2
CPT0206560003	Tumor	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis